Condition
Upper Extremity Deep Vein Thrombosis
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06603870Phase 4Recruiting
Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
NCT04499638Completed
Incidence of Complications of Peripheral Venous Access in the Type 2 Diabetic Population
NCT03506815Phase 3CompletedPrimary
Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines
NCT02489721CompletedPrimary
Major Complications Related to PICC and Midline Insertion
Showing all 4 trials